Medline Inc. (MDLN) Financial Statements
Medline Inc. (MDLN) reported trailing twelve-month revenue of $29.9B (up 11.5% year on year) and net income of $1.2B as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $1.5B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MDLNMedline Inc.Follow MDLN — free
—
Price chart with a free account
- Market cap
- 44.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Revenue | 23.23 | 25.51 | 28.43 | 29.94 | |
| Gross profit | 5.89 | 6.98 | 7.52 | 7.85 | |
| Research & development | — | — | 0.08 | — | |
| Operating income | 1.25 | 2.15 | 2.21 | 1.82 | |
| Pre-tax income | 0.26 | 1.25 | 1.25 | 1.08 | |
| Income tax | 0.03 | 0.05 | 0.09 | 0.20 | |
| Net income | 0.23 | 1.16 | 1.16 | — | |
| Diluted EPS ($) | — | — | -0.01 | — | |
| Diluted shares (bn) | — | — | 0.810 | — |
USD billions · SEC XBRL
Medline Inc. — questions
- What is Medline Inc.'s revenue?
- $29.9B over the twelve months to 2026-06-30, up 11.5% year on year, from its 10-Q and 10-K filings.
- What is Medline Inc.'s net income?
- $1.2B over the twelve months to 2026-06-30.
- What is Medline Inc.'s free cash flow?
- $1.5B over the twelve months to 2026-06-30.
Every figure on this page comes from Medline Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.